Early research (Phase 1)Active Not RecruitingNCT04485013What this trial is testingTTX-080 HLA-G Antagonist in Subjects With Advanced CancersWho this might be right forCancer Tizona Therapeutics, Inc 240
Large-scale testing (Phase 3)Study completedNCT01086618What this trial is testingChemotherapy With or Without Surgery in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by SurgeryWho this might be right forColorectal Cancer University College London Hospitals 500
Testing effectiveness (Phase 2)Active Not RecruitingNCT05620134What this trial is testingStudy of JK08 in Patients with Unresectable Locally Advanced or Metastatic CancerWho this might be right forCancerTumor, SolidAdvanced Solid Tumor+19 more Salubris Biotherapeutics Inc 263
Not applicableWithdrawnNCT04889495What this trial is testingA Post-marketing Surveillance to Assess the Safety and Effectiveness of Zirabev in Domestic Patients With Various CancerWho this might be right forNon-small Cell Lung CancerMetastatic Colorectal CancerMetastatic Breast Cancer+5 more Pfizer
Testing effectiveness (Phase 2)Study completedNCT01086267What this trial is testingSafety and Efficacy Study of BMS-908662 Alone or in Combination With Cetuximab in Subjects With K-RAS or B-RAF Mutation Positive Advanced or Metastatic Colorectal CancerWho this might be right forColorectal Cancer Bristol-Myers Squibb 17
Testing effectiveness (Phase 2)Study completedNCT01116271What this trial is testingStudy of Selumetinib (AZD6244)(ARRY-142886) in Combination With Irinotecan in Previously Treated Patients With ColorecWho this might be right forColorectal Cancer AstraZeneca 32
Early research (Phase 1)Active Not RecruitingNCT05787587What this trial is testingPARG Inhibitor IDE161 in Participants With Advanced Solid TumorsWho this might be right forAdvanced or Metastatic Solid TumorsBreast CancerOvarian Cancer+6 more IDEAYA Biosciences 216
Testing effectiveness (Phase 2)Study completedNCT00248404What this trial is testingNB1011 Administered by Continuous Infusion in Cancers That Overexpress Thymidylate Synthase (TS)Who this might be right forTumors Kiadis Pharma 155
Early research (Phase 1)Study completedNCT01787500What this trial is testingVemurafenib, Cetuximab, and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or That Cannot Be Removed by SurgeryWho this might be right forBRAF NP_004324.2:p.V600XKRAS wt AlleleMetastatic Malignant Solid Neoplasm+4 more M.D. Anderson Cancer Center 47
Testing effectiveness (Phase 2)Looking for participantsNCT07397338What this trial is testingStudy of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid TumorsWho this might be right forAdvanced Solid TumorsMetastatic Solid TumorsNon-small Cell Lung Cancer (NSCLC)+3 more Revolution Medicines, Inc. 370
Testing effectiveness (Phase 2)Looking for participantsNCT06265025What this trial is testingGM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid TumorsWho this might be right forHead and Neck CancerMalignant MelanomaColorectal Cancer+3 more GeneMedicine Co., Ltd. 125
Early research (Phase 1)Active Not RecruitingNCT05838768What this trial is testingStudy of HRO761 Alone or in Combination in Cancer Patients With Specific DNA Alterations Called Microsatellite Instability or Mismatch Repair Deficiency.Who this might be right forMSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including Colorectal Cancers Novartis Pharmaceuticals 123
Early research (Phase 1)Ended earlyNCT02703571What this trial is testingStudy of Safety and Efficacy of Ribociclib and Trametinib in Patients With Metastatic or Advanced Solid TumorsWho this might be right forSolid Tumors for Phase IbPancreatic Cancer for Phase IIColorectal Cancer for Phase II Novartis Pharmaceuticals 95
Early research (Phase 1)UnknownNCT05872867What this trial is testingStudy of WM-A1-3389 in Participants With Advanced or Metastatic Solid Tumors and Non-Small Cell Lung Cancer (MK-3475-E90/KEYNOTE-E90)Who this might be right forAdvanced Solid TumorMetastatic Solid TumorLung Cancer+5 more Wellmarker Bio 54
Early research (Phase 1)Looking for participantsNCT07454642What this trial is testingAVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid TumorsWho this might be right forVulvar AdenocarcinomaPDAC - Pancreatic Ductal AdenocarcinomaGastric Adenocarcinoma+6 more Avacta Life Sciences Ltd 174
Early research (Phase 1)Study completedNCT01761240What this trial is testingDose Escalation Study MORAb-066 Targeting Tissue Factor (TF)-Expressing Malignancies Including Breast, Pancreatic, Colorectal, NSCLCWho this might be right forBreast CancerPancreatic CancerColorectal Cancer+2 more Morphotek 27
Early research (Phase 1)Study completedNCT02110082What this trial is testingCombination Study of Urelumab and Cetuximab in Patients With Advanced/Metastatic Colorectal Cancer or Advanced/Metastatic Head and Neck CancerWho this might be right forColorectal CancerHead and Neck Cancer Bristol-Myers Squibb 66
Early research (Phase 1)Study completedNCT03289962What this trial is testingAutogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic TumorsWho this might be right forMelanomaNon-Small Cell Lung CancerBladder Cancer+5 more Genentech, Inc. 273
Testing effectiveness (Phase 2)Looking for participantsNCT04585750What this trial is testingThe Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)Who this might be right forAdvanced Solid TumorAdvanced Malignant NeoplasmMetastatic Cancer+27 more PMV Pharmaceuticals, Inc 300
Testing effectiveness (Phase 2)Ended earlyNCT04383210What this trial is testingStudy of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid TumorsWho this might be right forLocally Advanced Solid TumorMetastatic Solid TumorPancreatic Cancer+14 more Elevation Oncology 54